Company record · MRNA · Biological Products, (No Diagnostic Substances)
Moderna, Inc.
The principal financial officer who signed Moderna, Inc.'s latest annual report is James M. Mock, verified February 20, 2026.
Roster record
| Officer | James M. Mock |
|---|---|
| Verified | February 20, 2026 (filing date of the source) |
| Note | The DEF 14A filed 2026-03-16 does not name James M. Mock near a Chief Financial Officer title; check for a change. An 8-K with Item 5.02 was filed on 2026-07-08, after this 10-K; any CFO change it reports is tracked on the moves record. |
- sec.gov · signature block · “/s/ James M. Mock Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)”
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.